Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anticoagulants in pregnancy

M Greaves1

  • 1Department of Haematology, Royal Hallamshire Hospital, Sheffield, U.K.

Pharmacology & Therapeutics
|September 1, 1993
PubMed
Summary

Pregnancy increases blood clot risk, with pulmonary embolism a leading maternal death cause. Anticoagulant use in pregnancy requires careful risk-benefit assessment due to potential complications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single-cell analysis identifies CRLF2 rearrangements as both early and late events in Down syndrome and non-Down syndrome acute lymphoblastic leukaemia.

Leukemia·2018
Same author

Targeted lung cancer screening selects individuals at high risk of cardiovascular disease.

Lung cancer (Amsterdam, Netherlands)·2018
Same author

Possible role of pandemic AH1N1 swine flu virus in a childhood leukemia cluster.

Leukemia·2017
Same author

Carbon dating cancer: defining the chronology of metastatic progression in colorectal cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

So you want to publish your research in the Journal of Thrombosis and Haemostasis?

Journal of thrombosis and haemostasis : JTH·2016
Same author

A genome-wide association study identifies risk loci for childhood acute lymphoblastic leukemia at 10q26.13 and 12q23.1.

Leukemia·2016

Area of Science:

  • Obstetrics and Gynecology
  • Hematology
  • Pharmacology

Background:

  • Pregnancy naturally induces a prethrombotic state, elevating risks of venous thromboembolism.
  • Pulmonary embolism is a significant cause of maternal mortality, necessitating anticoagulant use.
  • Women with thrombophilic conditions face heightened risks during pregnancy.

Purpose of the Study:

  • To review anticoagulant use in pregnancy.
  • To highlight risks associated with common anticoagulants like heparin and warfarin.
  • To discuss management considerations for pregnant women requiring anticoagulation.

Main Methods:

  • Literature review of anticoagulant therapy in pregnancy.
  • Analysis of risks and benefits of heparin and warfarin.
  • Discussion of clinical management strategies.

Main Results:

  • Heparin is favored but carries risks (osteopenia, thrombocytopenia, hemorrhage).
  • Warfarin is teratogenic and poses hemorrhage risks to mother and fetus.
  • Limited clinical trial data complicates optimal regimen selection.

Conclusions:

  • Anticoagulant management in pregnancy demands individualized risk-benefit analysis.
  • Patient and clinician preferences influence treatment choices.
  • Further research is needed for evidence-based guidelines on anticoagulant use during pregnancy and postpartum.

Related Experiment Videos